Table of Contents 1 Anti-tumor Drug Market Overview 1.1 Product Overview and Scope of Anti-tumor Drug 1.2 Classification of Anti-tumor Drug by Type 1.2.1 Global Anti-tumor Drug Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Global Anti-tumor Drug Revenue Market Share by Type in 2019 1.2.3 Cytotoxic Drugs 1.2.4 Non-cytotoxic Drugs 1.3 Global Anti-tumor Drug Market by Application 1.3.1 Overview: Global Anti-tumor Drug Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Alkylating Agents 1.3.3 Anti-metabolism Drugs 1.3.4 Platinum Antineoplastic Agents 1.3.5 Anthracycline antitumor drugs 1.3.6 Microtubule Stabilizer 1.3.7 Endocrine Therapy Drugs 1.3.8 Immunotherapy Drugs 1.3.9 Gene Therapy Drugs 1.3.10 Targeted Antineoplastic Drugs 1.4 Global Anti-tumor Drug Market by Regions 1.4.1 Global Anti-tumor Drug Market Size by Regions: 2015 VS 2019 VS 2025 1.4.2 Global Market Size of Anti-tumor Drug (2015-2025) 1.4.3 North America (USA, Canada and Mexico) Anti-tumor Drug Status and Prospect (2015-2025) 1.4.4 Europe (Germany, France, UK, Russia and Italy) Anti-tumor Drug Status and Prospect (2015-2025) 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-tumor Drug Status and Prospect (2015-2025) 1.4.6 South America (Brazil, Argentina, Colombia) Anti-tumor Drug Status and Prospect (2015-2025) 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-tumor Drug Status and Prospect (2015-2025) 2 Company Profiles 2.1 Roche 2.1.1 Roche Details 2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Roche SWOT Analysis 2.1.4 Roche Product and Services 2.1.5 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.2 Takeda 2.2.1 Takeda Details 2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Takeda SWOT Analysis 2.2.4 Takeda Product and Services 2.2.5 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.3 Bristol-Myers Squibb 2.3.1 Bristol-Myers Squibb Details 2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Bristol-Myers Squibb SWOT Analysis 2.3.4 Bristol-Myers Squibb Product and Services 2.3.5 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.4 Novartis 2.4.1 Novartis Details 2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Novartis SWOT Analysis 2.4.4 Novartis Product and Services 2.4.5 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.5 Pfizer 2.5.1 Pfizer Details 2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Pfizer SWOT Analysis 2.5.4 Pfizer Product and Services 2.5.5 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.6 Celgene 2.6.1 Celgene Details 2.6.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Celgene SWOT Analysis 2.6.4 Celgene Product and Services 2.6.5 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.7 AstraZeneca 2.7.1 AstraZeneca Details 2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 AstraZeneca SWOT Analysis 2.7.4 AstraZeneca Product and Services 2.7.5 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.8 Johnson & Johnson 2.8.1 Johnson & Johnson Details 2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Johnson & Johnson SWOT Analysis 2.8.4 Johnson & Johnson Product and Services 2.8.5 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.9 Amgen 2.9.1 Amgen Details 2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 Amgen SWOT Analysis 2.9.4 Amgen Product and Services 2.9.5 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.10 Eli Lilly 2.10.1 Eli Lilly Details 2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 Eli Lilly SWOT Analysis 2.10.4 Eli Lilly Product and Services 2.10.5 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.11 Biogen Idec 2.11.1 Biogen Idec Details 2.11.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis 2.11.3 Biogen Idec SWOT Analysis 2.11.4 Biogen Idec Product and Services 2.11.5 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.12 Otsuka 2.12.1 Otsuka Details 2.12.2 Otsuka Major Business and Total Revenue (Financial Highlights) Analysis 2.12.3 Otsuka SWOT Analysis 2.12.4 Otsuka Product and Services 2.12.5 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.13 Astellas 2.13.1 Astellas Details 2.13.2 Astellas Major Business and Total Revenue (Financial Highlights) Analysis 2.13.3 Astellas SWOT Analysis 2.13.4 Astellas Product and Services 2.13.5 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.14 Eisai 2.14.1 Eisai Details 2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis 2.14.3 Eisai SWOT Analysis 2.14.4 Eisai Product and Services 2.14.5 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.15 Bayer 2.15.1 Bayer Details 2.15.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis 2.15.3 Bayer SWOT Analysis 2.15.4 Bayer Product and Services 2.15.5 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.16 Merck & Co 2.16.1 Merck & Co Details 2.16.2 Merck & Co Major Business and Total Revenue (Financial Highlights) Analysis 2.16.3 Merck & Co SWOT Analysis 2.16.4 Merck & Co Product and Services 2.16.5 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.17 Teva 2.17.1 Teva Details 2.17.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis 2.17.3 Teva SWOT Analysis 2.17.4 Teva Product and Services 2.17.5 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.18 Sanofi 2.18.1 Sanofi Details 2.18.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis 2.18.3 Sanofi SWOT Analysis 2.18.4 Sanofi Product and Services 2.18.3 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 3 Market Competition, by Players 3.1 Global Anti-tumor Drug Revenue and Share by Players (2015-2020) 3.2 Market Concentration Rate 3.2.1 Top 5 Anti-tumor Drug Players Market Share 3.2.2 Top 10 Anti-tumor Drug Players Market Share 3.3 Market Competition Trend 4 Market Size by Regions 4.1 Global Anti-tumor Drug Revenue and Market Share by Regions 4.2 North America Anti-tumor Drug Revenue and Growth Rate (2015-2020) 4.3 Europe Anti-tumor Drug Revenue and Growth Rate (2015-2020) 4.4 Asia-Pacific Anti-tumor Drug Revenue and Growth Rate (2015-2020) 4.5 South America Anti-tumor Drug Revenue and Growth Rate (2015-2020) 4.6 Middle East & Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020) 5 North America Anti-tumor Drug Revenue by Countries 5.1 North America Anti-tumor Drug Revenue by Countries (2015-2020) 5.2 USA Anti-tumor Drug Revenue and Growth Rate (2015-2020) 5.3 Canada Anti-tumor Drug Revenue and Growth Rate (2015-2020) 5.4 Mexico Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6 Europe Anti-tumor Drug Revenue by Countries 6.1 Europe Anti-tumor Drug Revenue by Countries (2015-2020) 6.2 Germany Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6.3 UK Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6.4 France Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6.5 Russia Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6.6 Italy Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7 Asia-Pacific Anti-tumor Drug Revenue by Countries 7.1 Asia-Pacific Anti-tumor Drug Revenue by Countries (2015-2020) 7.2 China Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7.3 Japan Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7.4 Korea Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7.5 India Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7.6 Southeast Asia Anti-tumor Drug Revenue and Growth Rate (2015-2020) 8 South America Anti-tumor Drug Revenue by Countries 8.1 South America Anti-tumor Drug Revenue by Countries (2015-2020) 8.2 Brazil Anti-tumor Drug Revenue and Growth Rate (2015-2020) 8.3 Argentina Anti-tumor Drug Revenue and Growth Rate (2015-2020) 9 Middle East & Africa Revenue Anti-tumor Drug by Countries 9.1 Middle East & Africa Anti-tumor Drug Revenue by Countries (2015-2020) 9.2 Saudi Arabia Anti-tumor Drug Revenue and Growth Rate (2015-2020) 9.3 UAE Anti-tumor Drug Revenue and Growth Rate (2015-2020) 9.4 Egypt Anti-tumor Drug Revenue and Growth Rate (2015-2020) 9.5 South Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020) 10 Market Size Segment by Type 10.1 Global Anti-tumor Drug Revenue and Market Share by Type (2015-2020) 10.2 Global Anti-tumor Drug Market Forecast by Type (2019-2024) 10.3 Cytotoxic Drugs Revenue Growth Rate (2015-2025) 10.4 Non-cytotoxic Drugs Revenue Growth Rate (2015-2025) 11 Global Anti-tumor Drug Market Segment by Application 11.1 Global Anti-tumor Drug Revenue Market Share by Application (2015-2020) 11.2 Anti-tumor Drug Market Forecast by Application (2019-2024) 11.3 Alkylating Agents Revenue Growth (2015-2020) 11.4 Anti-metabolism Drugs Revenue Growth (2015-2020) 11.5 Platinum Antineoplastic Agents Revenue Growth (2015-2020) 11.6 Anthracycline antitumor drugs Revenue Growth (2015-2020) 11.7 Microtubule Stabilizer Revenue Growth (2015-2020) 11.8 Endocrine Therapy Drugs Revenue Growth (2015-2020) 11.9 Immunotherapy Drugs Revenue Growth (2015-2020) 11.10 Gene Therapy Drugs Revenue Growth (2015-2020) 11.11 Targeted Antineoplastic Drugs Revenue Growth (2015-2020) 12 Global Anti-tumor Drug Market Size Forecast (2021-2025) 12.1 Global Anti-tumor Drug Market Size Forecast (2021-2025) 12.2 Global Anti-tumor Drug Market Forecast by Regions (2021-2025) 12.3 North America Anti-tumor Drug Revenue Market Forecast (2021-2025) 12.4 Europe Anti-tumor Drug Revenue Market Forecast (2021-2025) 12.5 Asia-Pacific Anti-tumor Drug Revenue Market Forecast (2021-2025) 12.6 South America Anti-tumor Drug Revenue Market Forecast (2021-2025) 12.7 Middle East & Africa Anti-tumor Drug Revenue Market Forecast (2021-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source 14.3 Disclaimer 14.4 About US

List of Tables Table 1. Global Anti-tumor Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Anti-tumor Drug by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Anti-tumor Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Global Market Anti-tumor Drug Revenue (Million USD) Comparison by Regions 2015-2025 Table 5. Roche Corporate Information, Location and Competitors Table 6. Roche Anti-tumor Drug Major Business Table 7. Roche Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 8. Roche SWOT Analysis Table 9. Roche Anti-tumor Drug Product and Solutions Table 10. Roche Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 11. Takeda Corporate Information, Location and Competitors Table 12. Takeda Anti-tumor Drug Major Business Table 13. Takeda Anti-tumor Drug Total Revenue (USD Million) (2018-2019) Table 14. Takeda SWOT Analysis Table 15. Takeda Anti-tumor Drug Product and Solutions Table 16. Takeda Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 17. Bristol-Myers Squibb Corporate Information, Location and Competitors Table 18. Bristol-Myers Squibb Anti-tumor Drug Major Business Table 19. Bristol-Myers Squibb Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 20. Bristol-Myers Squibb SWOT Analysis Table 21. Bristol-Myers Squibb Anti-tumor Drug Product and Solutions Table 22. Bristol-Myers Squibb Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 23. Novartis Corporate Information, Location and Competitors Table 24. Novartis Anti-tumor Drug Major Business Table 25. Novartis Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 26. Novartis SWOT Analysis Table 27. Novartis Anti-tumor Drug Product and Solutions Table 28. Novartis Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 29. Pfizer Corporate Information, Location and Competitors Table 30. Pfizer Anti-tumor Drug Major Business Table 31. Pfizer Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 32. Pfizer SWOT Analysis Table 33. Pfizer Anti-tumor Drug Product and Solutions Table 34. Pfizer Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 35. Celgene Corporate Information, Location and Competitors Table 36. Celgene Anti-tumor Drug Major Business Table 37. Celgene Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 38. Celgene SWOT Analysis Table 39. Celgene Anti-tumor Drug Product and Solutions Table 40. Celgene Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 41. AstraZeneca Corporate Information, Location and Competitors Table 42. AstraZeneca Anti-tumor Drug Major Business Table 43. AstraZeneca Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 44. AstraZeneca SWOT Analysis Table 45. AstraZeneca Anti-tumor Drug Product and Solutions Table 46. AstraZeneca Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 47. Johnson & Johnson Corporate Information, Location and Competitors Table 48. Johnson & Johnson Anti-tumor Drug Major Business Table 49. Johnson & Johnson Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 50. Johnson & Johnson SWOT Analysis Table 51. Johnson & Johnson Anti-tumor Drug Product and Solutions Table 52. Johnson & Johnson Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 53. Amgen Corporate Information, Location and Competitors Table 54. Amgen Anti-tumor Drug Major Business Table 55. Amgen Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 56. Amgen SWOT Analysis Table 57. Amgen Anti-tumor Drug Product and Solutions Table 58. Amgen Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 59. Eli Lilly Corporate Information, Location and Competitors Table 60. Eli Lilly Anti-tumor Drug Major Business Table 61. Eli Lilly Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 62. Eli Lilly SWOT Analysis Table 63. Eli Lilly Anti-tumor Drug Product and Solutions Table 64. Eli Lilly Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 65. Biogen Idec Corporate Information, Location and Competitors Table 66. Biogen Idec Anti-tumor Drug Major Business Table 67. Biogen Idec Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 68. Biogen Idec SWOT Analysis Table 69. Biogen Idec Anti-tumor Drug Product and Solutions Table 70. Biogen Idec Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 71. Otsuka Corporate Information, Location and Competitors Table 72. Otsuka Anti-tumor Drug Major Business Table 73. Otsuka Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 74. Otsuka SWOT Analysis Table 75. Otsuka Anti-tumor Drug Product and Solutions Table 76. Otsuka Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 77. Astellas Corporate Information, Location and Competitors Table 78. Astellas Anti-tumor Drug Major Business Table 79. Astellas Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 80. Astellas SWOT Analysis Table 81. Astellas Anti-tumor Drug Product and Solutions Table 82. Astellas Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 83. Eisai Corporate Information, Location and Competitors Table 84. Eisai Anti-tumor Drug Major Business Table 85. Eisai Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 86. Eisai SWOT Analysis Table 87. Eisai Anti-tumor Drug Product and Solutions Table 88. Eisai Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 89. Bayer Corporate Information, Location and Competitors Table 90. Bayer Anti-tumor Drug Major Business Table 91. Bayer Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 92. Bayer SWOT Analysis Table 93. Bayer Anti-tumor Drug Product and Solutions Table 94. Bayer Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 95. Merck & Co Corporate Information, Location and Competitors Table 96. Merck & Co Anti-tumor Drug Major Business Table 97. Merck & Co Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 98. Merck & Co SWOT Analysis Table 99. Merck & Co Anti-tumor Drug Product and Solutions Table 100. Merck & Co Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 101. Teva Corporate Information, Location and Competitors Table 102. Teva Anti-tumor Drug Major Business Table 103. Teva Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 104. Teva SWOT Analysis Table 105. Teva Anti-tumor Drug Product and Solutions Table 106. Teva Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 107. Sanofi Anti-tumor Drug Type and Application Table 108. Sanofi Anti-tumor Drug Major Business Table 109. Sanofi Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 110. Sanofi SWOT Analysis Table 111. Sanofi Anti-tumor Drug Product and Solutions Table 112. Sanofi Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 113. Global Anti-tumor Drug Revenue (Million USD) by Players (2015-2020) Table 114. Global Anti-tumor Drug Revenue Share by Players (2015-2020) Table 115. Global Anti-tumor Drug Revenue (Million USD) by Regions (2015-2020) Table 116. Global Anti-tumor Drug Revenue Market Share by Regions (2015-2020) Table 117. North America Anti-tumor Drug Revenue by Countries (2015-2020) Table 118. North America Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Table 119. Europe Anti-tumor Drug Revenue (Million USD) by Countries (2015-2020) Table 120. Asia-Pacific Anti-tumor Drug Revenue (Million USD) by Countries (2015-2020) Table 121. South America Anti-tumor Drug Revenue by Countries (2015-2020) Table 122. South America Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Table 123. Middle East and Africa Anti-tumor Drug Revenue (Million USD) by Countries (2015-2020) Table 124. Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Table 125. Global Anti-tumor Drug Revenue (Million USD) by Type (2015-2020) Table 126. Global Anti-tumor Drug Revenue Share by Type (2015-2020) Table 127. Global Anti-tumor Drug Revenue Forecast by Type (2021-2025) Table 128. Global Anti-tumor Drug Revenue by Application (2015-2020) Table 129. Global Anti-tumor Drug Revenue Share by Application (2015-2020) Table 130. Global Anti-tumor Drug Revenue Forecast by Application (2021-2025) Table 131. Global Anti-tumor Drug Revenue (Million USD) Forecast by Regions (2021-2025) List of Figures Figure 1. Anti-tumor Drug Picture Figure 2. Global Anti-tumor Drug Revenue Market Share by Type in 2019 Figure 3. Cytotoxic Drugs Picture Figure 4. Non-cytotoxic Drugs Picture Figure 5. Anti-tumor Drug Revenue Market Share by Application in 2019 Figure 6. Alkylating Agents Picture Figure 7. Anti-metabolism Drugs Picture Figure 8. Platinum Antineoplastic Agents Picture Figure 9. Anthracycline antitumor drugs Picture Figure 10. Microtubule Stabilizer Picture Figure 11. Endocrine Therapy Drugs Picture Figure 12. Immunotherapy Drugs Picture Figure 13. Gene Therapy Drugs Picture Figure 14. Targeted Antineoplastic Drugs Picture Figure 15. Global Anti-tumor Drug Revenue (USD Million) and Growth Rate (2015-2025) Figure 16. North America Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 17. Europe Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 18. Asia-Pacific Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 19. South America Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 20. Middle East and Africa Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 21. Global Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 22. Global Anti-tumor Drug Revenue Share by Players in 2019 Figure 23. Global Top 5 Players Anti-tumor Drug Revenue Market Share in 2019 Figure 24. Global Top 10 Players Anti-tumor Drug Revenue Market Share in 2019 Figure 25. Key Players Market Share Trend Figure 26. Global Anti-tumor Drug Revenue (Million USD) and Growth Rate (%) (2015-2020) Figure 27. Global Anti-tumor Drug Revenue Market Share by Regions (2015-2020) Figure 28. Global Anti-tumor Drug Revenue Market Share by Regions in 2018 Figure 29. North America Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 30. Europe Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 31. Asia-Pacific Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 32. South America Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 33. Middle East and Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 34. North America Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 35. North America Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 36. USA Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 37. Canada Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 38. Mexico Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 39. Europe Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 40. Europe Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 41. Germany Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 42. UK Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 43. France Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 44. Russia Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 45. Italy Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 46. Asia-Pacific Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 47. Asia-Pacific Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 48. China Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 49. Japan Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 50. Korea Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 51. India Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 52. Southeast Asia Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 53. South America Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 54. South America Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 55. Brazil Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 56. Argentina Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 57. Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 58. Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 59. Saudi Arabia Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 60. UAE Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 61. Egypt Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 62. South Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 63. Global Anti-tumor Drug Revenue Share by Type (2015-2020) Figure 64. Global Anti-tumor Drug Revenue Share by Type in 2019 Figure 65. Global Anti-tumor Drug Market Share Forecast by Type (2021-2025) Figure 66. Global Cytotoxic Drugs Revenue Growth Rate (2015-2020) Figure 67. Global Non-cytotoxic Drugs Revenue Growth Rate (2015-2020) Figure 68. Global Anti-tumor Drug Revenue Share by Application (2015-2020) Figure 69. Global Anti-tumor Drug Revenue Share by Application in 2019 Figure 70. Global Anti-tumor Drug Market Share Forecast by Application (2021-2025) Figure 71. Global Alkylating Agents Revenue Growth Rate (2015-2020) Figure 72. Global Anti-metabolism Drugs Revenue Growth Rate (2015-2020) Figure 73. Global Platinum Antineoplastic Agents Revenue Growth Rate (2015-2020) Figure 74. Global Anthracycline antitumor drugs Revenue Growth Rate (2015-2020) Figure 75. Global Microtubule Stabilizer Revenue Growth Rate (2015-2020) Figure 76. Global Endocrine Therapy Drugs Revenue Growth Rate (2015-2020) Figure 77. Global Immunotherapy Drugs Revenue Growth Rate (2015-2020) Figure 78. Global Gene Therapy Drugs Revenue Growth Rate (2015-2020) Figure 79. Global Targeted Antineoplastic Drugs Revenue Growth Rate (2015-2020) Figure 80. Global Anti-tumor Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025) Figure 81. Global Anti-tumor Drug Revenue (Million USD) Forecast by Regions (2021-2025) Figure 82. Global Anti-tumor Drug Revenue Market Share Forecast by Regions (2021-2025) Figure 83. North America Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 84. Europe Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 85. Asia-Pacific Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 86. South America Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 87. Middle East and Africa Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 88. Sales Channel: Direct Channel vs Indirect Channel